First cases of Omicron in France are exhibiting mild symptoms, November 2021-January 20222021년 11월부터 2022년 1월까지 프랑스에서 오미크론의 첫 번째 사례가 경미한 증상을 나타냅니다.Article Published on 2022-05-012022-09-11 Journal: Infectious diseases now [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] Admission age Characteristics COVID-19 death detect dose doses Epidemiology exhibiting France Healthcare system highlight Hospitalized information intensive care investigated Loss loss of smell and taste median age Mild mild symptoms National omicron questionnaire Questionnaires reported SARS-CoV-2 SIGN Signs and symptoms supporting information Surveillance survey surveys and questionnaires symptomatic Taste variant was used [DOI] 10.1016/j.idnow.2022.02.003 PMC 바로가기 [Article Type] Article
Is saliva collected passively without forceful coughing sensitive to detect SARS-CoV-2 in ambulatory cases? A systematic review보행 시 SARS-CoV-2 검출에 민감한 기침을 하지 않고 수동적으로 침을 채취합니까? 체계적인 검토Review Published on 2022-05-012022-09-11 Journal: Oral surgery, oral medicine, oral pathology and or [Category] COVID19(2023년), SARS, 치료기술, [키워드] absence Asymptomatic Chain Reaction Cohort collected conducted coughing cross-sectional detect inclusion criteria lack limitation Lower mildly symptomatic patient mildly symptomatic patients nasopharyngeal sample Nasopharyngeal samples nasopharyngeal swabs polymerase chain polymerase chain reaction Previous studies Prospective reported reverse transcription reverse transcription polymerase chain reaction RT-PCR Saliva sample collection SARS-CoV-2 SARS-CoV-2 detection sensitivity severity stages supervision symptomatic systematic review the disease Viral load was performed [DOI] 10.1016/j.oooo.2022.01.002 PMC 바로가기 [Article Type] Review
Obstetric-Neonatal Care during Birth and Postpartum in Symptomatic and Asymptomatic Women Infected with SARS-CoV-2: A Retrospective Multicenter StudyObservational Study Published on 2022-04-302022-10-05 Journal: International Journal of Environmental Research an [Category] COVID19(2023년), SARS, 임상, [키워드] Admission Analysis Asymptomatic Birth Care carried Community Complication Contact COVID-19 eight greater had more ICU increased risk Infant infected with SARS-CoV-2 intensive care intensive care unit Labour lack less mortality rate multicenter multicenter study Neonatal neonatal nursing NICU NICU admissions Obstetric obstetric nursing. offspring outcome Postpartum Preterm birth Public Hospital retrospective SARS-CoV-2 Spain Symptom symptomatic symptomatic and asymptomatic transfer Transmission Valencian was recorded women [DOI] 10.3390/ijerph19095482 PMC 바로가기 [Article Type] Observational Study
Comparison of Analytical Values D-Dimer, Glucose, Ferritin and C-Reactive Protein of Symptomatic and Asymptomatic COVID-19 Patients증상 및 무증상 COVID-19 환자의 D-이량체, 포도당, 페리틴 및 C-반응성 단백질의 분석 값 비교Article Published on 2022-04-282022-09-11 Journal: International Journal of Environmental Research an [Category] COVID19(2023년), SARS, 바이오마커, [키워드] age alteration analysed Asymptomatic asymptomatic patients Biomarkers C-reactive protein C-reactive protein) carried chain Chain Reaction Complication correlated COVID-19 cross-sectional cross-sectional study D-dimer develop evaluate ferritins Frequency Glucose glucose. hospitalisation hospitalised involved Laboratory less mild symptoms occurred parameter parameters participant pathology Patient patients polymerase chain reaction positive predict predictor reaction reduce risk Serum ferritin severe symptom severe symptoms severity Spain statistically significant statistically significant difference symptomatic symptomatic patient test result the patient value [DOI] 10.3390/ijerph19095354 PMC 바로가기 [Article Type] Article
Ivermectin for the prevention of COVID-19: addressing potential bias and medical fraudCOVID-19 예방을 위한 Ivermectin: 잠재적 편견 및 의료 사기 해결Meta-Analysis Published on 2022-04-272022-09-11 Journal: Journal of Antimicrobial Chemotherapy [Category] 임상, [키워드] Analysis antiparasitic drug clinical trial clinical trials conducted COVID-19 COVID-19 infection high risk investigated Ivermectin measure Meta-analysis multi-arm poor quality post-hoc analysis prevention of COVID-19 Primary outcome Quality Randomized controlled trial Randomized controlled trials randomized trial raw data risk of bia RoB 2 RT-PCR secondary outcome significant effect subgroup analysis symptomatic symptomatic COVID-19 Trial trials [DOI] 10.1093/jac/dkac052 PMC 바로가기 [Article Type] Meta-Analysis
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study오미크론 및 델타 변이가 우세한 기간 동안 SARS-CoV-2에 감염된 개인의 증상 유병률, 기간 및 입원 위험: ZOE COVID 연구의 전향적 관찰 연구Observational Study Published on 2022-04-232022-09-11 Journal: Lancet (London, England) [Category] COVID19(2023년), SARS, 변종, 임상, [키워드] 1:1 95% CI age appear body-mass body-mass index chronic chronic disease collected data COVID dose Eligible participants foundation Hospital admission individual infected with SARS-CoV-2 Infection infectiousness lateral flow result less likelihood Loss Loss of Smell Lower respiratory tract Medical Research Council observational study Odds ratio omicron participant Patient PCR positive Positive test Prevalence prevalent Primary outcome Probability prospective observational study public health reduced reported symptom reported symptoms risk SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 variant Sex sore sore throat study period Symptom symptom duration symptomatic tested vaccination variant Wellcome Trust [DOI] 10.1016/S0140-6736(22)00327-0 PMC 바로가기 [Article Type] Observational Study
Comparison of UK paediatric SARS-CoV-2 admissions across the first and second pandemic waves Research Published on 2022-04-222022-10-05 Journal: Pediatric Research [Category] COVID19(2023년), SARS, 치료제, [키워드] Admission Alpha antibiotic use B.1.1.7 changes in Characteristics children clinical Clinical characteristics co-morbidity Cohort Comorbidity Critical care died disease severity Evidence First wave had no hospitalised hospitals hypothesised Impact less main analysis MIS-C multicentre no evidence of Observational cohort study pandemic Patient proportion Prospective reported Respiratory Support Result SAGE SARS-CoV-2 SARS-COV-2 infection score second wave severity of COVID-19 shielding Support symptomatic those with MIS-C Treatment vaccination variant were excluded [DOI] 10.1038/s41390-022-02052-5 [Article Type] Research
App-based COVID-19 syndromic surveillance and prediction of hospital admissions in COVID Symptom Study Sweden Research Published on 2022-04-212022-10-05 Journal: Nature Communications [Category] 임상, 치료기술, [키워드] 95% CI AUC contribute contributed COVID COVID-19 COVID-19 test dataset English enrolled error rate FIVE highlighting hospital Hospital admission Hospital admissions include Local median observé pandemic PCR test predict Prevalence Probability Region second wave study participant Surveillance Symptom symptomatic turn [DOI] 10.1038/s41467-022-29608-7 [Article Type] Research
An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients경증 및 중등도 입원 코비드-19 환자를 위한 인도메타신의 공개 라벨 무작위 임상 시험Randomized Controlled Trial Published on 2022-04-192022-09-12 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 신약개발, 임상, 진단, 치료법, 치료제, [키워드] addition adjuvant therapies Admission adverse event afebrile anti-inflammatory drug Antiviral Arm ARMS Block randomisation blood chemistry clinical trial control arm coronavirus disease cough COVID-19 COVID-19 patient Desaturation discharge effective Efficacy and safety evaluated Fever Follow-up High-flow oxygen hospital hospitalised indomethacin Ivermectin medication Mild moderate myalgia open label Paracetamol parameters Patient patients primary endpoint profile provided randomised randomized clinical trial reported required retained Safe Secondary endpoints Standard of care Symptom symptomatic tiredness [DOI] 10.1038/s41598-022-10370-1 PMC 바로가기 [Article Type] Randomized Controlled Trial
Opening up safely: public health system requirements for ongoing COVID-19 management based on evaluation of Australia’s surveillance system performance안전한 개방: 호주의 감시 시스템 성능 평가를 기반으로 한 지속적인 COVID-19 관리를 위한 공중 보건 시스템 요구 사항Article Published on 2022-04-152022-09-11 Journal: BMC Medicine [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 치료기술, [키워드] acute respiratory illness acute respiratory syndrome acute respiratory syndrome coronavirus Analysis available data average Characteristics Cluster Community community transmission coronavirus coronavirus disease Coronavirus disease 2019 Coverage COVID-19 Critical described detection eliminated Engagement epidemiological epidemiologically evaluated FIVE General population genomic sequencing Government increase in International maintenance management mechanism opening Other outbreak Outbreaks performed positive Public public health public health measure quarantine SARS-CoV-2 sensitivity sequencing data severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 state study period Support supported Surveillance symptomatic Timeliness to define Transmission vaccination Vaccine variant variants variants of concern VOCs was tested [DOI] 10.1186/s12916-022-02344-x PMC 바로가기 [Article Type] Article